Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Nutex Health (NUTX) Cash & Current Investments (2016 - 2026)

Nutex Health (NUTX) has disclosed Cash & Current Investments for 17 consecutive years, with $210.6 million as the latest value for Q1 2026.

  • For Q1 2026, Cash & Current Investments rose 140.26% year-over-year to $210.6 million; the TTM value through Mar 2026 reached $210.6 million, up 140.26%, while the annual FY2025 figure was $185.9 million, 326.5% up from the prior year.
  • Cash & Current Investments hit $210.6 million in Q1 2026 for Nutex Health, up from $185.9 million in the prior quarter.
  • Across five years, Cash & Current Investments topped out at $210.6 million in Q1 2026 and bottomed at $3.3 million in Q1 2022.
  • Average Cash & Current Investments over 5 years is $67.3 million, with a median of $40.8 million recorded in 2024.
  • Year-over-year, Cash & Current Investments tumbled 82.64% in 2022 and then skyrocketed 909.53% in 2023.
  • Nutex Health's Cash & Current Investments stood at $34.3 million in 2022, then tumbled by 35.77% to $22.0 million in 2023, then soared by 98.08% to $43.6 million in 2024, then soared by 326.5% to $185.9 million in 2025, then increased by 13.33% to $210.6 million in 2026.
  • According to Business Quant data, Cash & Current Investments over the past three periods came in at $210.6 million, $185.9 million, and $166.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.